机译:与Brincidofovir和Valganciclovir对抗物种C腺病毒感染的联合治疗免疫抑制的叙利亚仓鼠模型允许两种化合物的剂量大幅度减少
Saint Louis University School of Medicine Department of Molecular Microbiology and Immunology;
Saint Louis University School of Medicine Department of Molecular Microbiology and Immunology;
Saint Louis University School of Medicine Department of Molecular Microbiology and Immunology;
Saint Louis University School of Medicine Department of Molecular Microbiology and Immunology;
Saint Louis University School of Medicine Department of Molecular Microbiology and Immunology;
Adenovirus; Brincidofovir; Valganciclovir; Combination; Hamster;
机译:与Brincidofovir和Valganciclovir对抗物种C腺病毒感染的联合治疗免疫抑制的叙利亚仓鼠模型允许两种化合物的剂量大幅度减少
机译:Valganciclovir抑制人类腺病毒在允许的免疫抑制雌性和雄性叙利亚仓鼠中复制和病理。
机译:叙利亚仓鼠模型采用T细胞转移和溶瘤腺病毒组合疗法
机译:针对黄病毒感染治疗的鼠标和仓鼠模型
机译:溶瘤腺病毒载体和癌症治疗:在免疫能力强的叙利亚仓鼠模型中评估宿主免疫系统在载体抗肿瘤功效和毒性中的作用
机译:Valganciclovir抑制人类腺病毒在允许的免疫抑制雌性和雄性叙利亚仓鼠中复制和病理。
机译:Valganciclovir抑制免疫抑制的雌性和雄性叙利亚仓鼠中的人腺病毒复制和病理